Download PDF

Other users also viewed these articles

Antibiotic consumption, genetic risk and incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study Ziming Zheng; Yumei Huang; Jijuan Zhang; Jinchi Xie; An Pan; Yunfei Liao; Yu Zhang;
10.1016/j.aohep.2025.102136
The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease Francisco Barrera; Javier Uribe; Nixa Olvares; Paula Huerta; Daniel Cabrera; Manuel Romero-Gómez;
Ann Hepatol. 2024;29:
Metabolic dysfunction: The silenced connection with fatty liver disease Mariana M. Ramírez-Mejía; Xingshun Qi; Ludovico Abenavoli; Manuel Romero-Gómez; Mohammed Eslam; Nahum Méndez-Sánchez;
Ann Hepatol. 2023;28: